JESSICA BROWN: Open Payments
NPI 1003329236 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 14 payments from 9 companies in 2025. Trend: 2023 $343 · 2024 $835 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Abbott Laboratories | 1 | $59 |
| Amgen Inc. | 3 | $48 |
| PFIZER INC. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: CARDIOMEMS, Kerendia, REPATHA, ONPATTRO, JARDIANCE, Adempas, VYNDAQEL, WATCHMAN FLX.
Industry payments across TX — which companies pay providers there.
